-
Mashup Score: 0
What is agitation in Alzheimer’s disease (AAD)? Why is it important? Drs Porsteinsson, Culpepper, and Atri discuss ways to manage this distressing symptom.
Source: MedscapeCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 3
What is agitation in Alzheimer’s disease (AAD)? Why is it important? Drs Porsteinsson, Culpepper, and Atri discuss ways to manage this distressing symptom.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
📍 What is agitation in #Alzheimer's disease? Why is it important? Experts discuss ways to manage this distressing symptom. #AAD #MedEd #CME #MedTwitter #PsychTwitter ➡️ https://t.co/rDcv3phLMK https://t.co/pFPWo0suYB
-
-
Mashup Score: 1
What is agitation in Alzheimer’s disease (AAD)? Why is it important? Drs Porsteinsson, Culpepper, and Atri discuss ways to manage this distressing symptom.
Source: MedscapeCategories: Latest Headlines, NeurologyTweet-
📍 What is agitation in #Alzheimer's disease? Why is it important? Experts discuss ways to manage this distressing symptom. #AAD #MedEd #CME #MedTwitter #NeuroTwitter ➡️ https://t.co/Su4FoPL3fa https://t.co/8NBjoz7gWi
-
-
Mashup Score: 0
What is agitation in Alzheimer’s disease (AAD)? Why is it important? Drs Porsteinsson, Culpepper, and Atri discuss ways to manage this distressing symptom.
Source: MedscapeCategories: Latest Headlines, PsychiatryTweet-
📍 What is agitation in #Alzheimer's disease? Why is it important? Experts discuss ways to manage this distressing symptom. #AAD #MedEd #CME #MedTwitter #PsychTwitter ➡️ https://t.co/RSeezQTprU https://t.co/DhBjcCjcDE
-
-
Mashup Score: 4Exploring the Diagnosis and Management of Agitation in Alzheimer's Disease: An Assessment of Practice - 1 year(s) ago
Test your knowledge: Are you able to recognize and manage agitation in Alzheimer’s disease (AAD)?
Source: MedscapeCategories: Latest Headlines, PsychiatryTweet-
📝 Test your knowledge: Are you able to recognize & manage agitation in #Alzheimer's disease? #AAD #MedEd #CME #MedTwitter #PsychTwitter ➡️ https://t.co/Dlx7NPKeDC https://t.co/mi5o7c3Q4e
-
-
Mashup Score: 3Exploring the Diagnosis and Management of Agitation in Alzheimer's Disease: An Assessment of Practice - 1 year(s) ago
Test your knowledge: Are you able to recognize and manage agitation in Alzheimer’s disease (AAD)?
Source: MedscapeCategories: Latest Headlines, NeurologyTweet-
📝 Test your knowledge: Are you able to recognize & manage agitation in #Alzheimer's disease? #AAD #MedEd #CME #MedTwitter #NeuroTwitter ➡️ https://t.co/NUNbgoOnYW https://t.co/jnVSZseEj4
-
-
Mashup Score: 0Exploring the Diagnosis and Management of Agitation in Alzheimer's Disease: An Assessment of Practice - 1 year(s) ago
Test your knowledge: Are you able to recognize and manage agitation in Alzheimer’s disease (AAD)?
Source: MedscapeCategories: Latest HeadlinesTweet-
📝 Test your knowledge: Are you able to recognize and manage agitation in #Alzheimer's disease? #AAD #MedEd #CME #MedTwitter #PsychTwitter ➡️ https://t.co/Qu2t76BJQJ https://t.co/AfESOI0RKL
-
-
Mashup Score: 0Exploring the Diagnosis and Management of Agitation in Alzheimer's Disease: An Assessment of Practice - 1 year(s) ago
Test your knowledge: Are you able to recognize and manage agitation in Alzheimer’s disease (AAD)?
Source: MedscapeCategories: Latest HeadlinesTweet-
📝 Test your knowledge: Are you able to recognize and manage agitation in #Alzheimer's disease? #AAD #MedEd #CME #MedTwitter #NeuroTwitter ➡️ https://t.co/CC03HEgT2W https://t.co/kDiGdPItxG
-
-
Mashup Score: 0Home - JDDonline - Journal of Drugs in Dermatology - 1 year(s) ago
The Journal of Drugs in Dermatology (JDD) is a monthly, peer-reviewed, indexed dermatology journal and online resource.
Categories: Dermatology, Latest HeadlinesTweet-
The November Dermatology Roundup is live on https://t.co/IFbTK9Fosx - Life-Saving Recommendation Leads to AAD Recognition; NEA’s EczemaWise Receives Honors. Read now: https://t.co/NNl04S95vZ . . . #AAD #derm #dermatology #eczema #NEA #dermatologist https://t.co/3i3BYTDjol
-
-
Mashup Score: 2Study Finds Catheter Ablation Significantly Lowers Risk of Dementia in Patients with Atrial Fibrillation - 1 year(s) ago
November 10, 2022 — Biosense Webster, Inc., the global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi, announced today that data from a Biosense Webster-sponsored study that compares the risk of dementia in patients with atrial fibrillation (AFib) who were treated with catheter ablation (CA) versus anti-arrhythmic drugs (AAD) was published in the American Heart…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @BiosenseWebster Data from a Biosense Webster-sponsored #study that compares the risk of #dementia in patients with #atrialfibrillation (#AFib) who were treated with #catheterablation (CA) versus anti-arrhythmic drugs (#AAD) was published: https://t.co/LS3Y24nQlU
-
📍 What is agitation in #Alzheimer's disease? Why is it important? Experts discuss ways to manage this distressing symptom. #AAD #MedEd #CME #MedTwitter #NeuroTwitter #Alzheimersdisease ➡️ https://t.co/0o92ZhszHM https://t.co/0hKRtgNfak